According to a recent review of clinical guideline development, the obstetric and gynecologic literature increasingly provides evidence that standardization of care not only improves patient outcomes but also ahs a positive effect on malpractice litigation.
According to a recent review of clinical guideline development, the obstetric and gynecologic literature increasingly provides evidence that standardization of care not only improves patient outcomes but also has a positive effect on malpractice litigation. Clinical practice guidelines have been developed by specialty organizations such as the American College of Obstetricians and Gynecologists, government-supported groups, hospitals or group practices, and authors of review articles.
The review cites the experience of the Hospital Corporation of America as an example of these positive effects. After an analysis of its obstetric malpractice experience showed that obstetric claims were especially high for particular drugs and procedures, the hospital network developed checklist-driven protocols (eg, for oxytocin administration) and procedure-documentation templates, coupled with mandatory online education modules. The corporation found that patient outcomes improved and that during the past 8 years, obstetric professional liability claims dropped by about half and costs for defending claims decreased fivefold.
In another example, an investigation by the RAND Institute for Civil Justice showed that in California hospitals, a decrease of 10 patient-safety-indicator adverse events in a given year was associated with a decrease of 3.7 malpractice claims. This analysis was valid for surgeons, nonsurgical physicians, and ob/gyns.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More